Multidisciplinary management improves pregnancy outcomes in individuals with antiphospholipid antibodies, suggesting the need for standardized treatments.
Obstetric APS remains a major cause of maternal-fetal morbidity. Advances in understanding placental inflammation have expanded potential therapeutic targets, but standardized treatment remains limited. Optimal care requires risk-stratified, multidisciplinary management and further research to improve pregnancy outcomes.
No takes yet. Share an insight, caveat, or question.
Mills et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: